Board director since 1 February 2018
Michel began his career at Continental Bank SA, Belgium, before spending 18 years with The Dow Chemical Company in several finance and strategy responsibilities in Benelux, France, the US and Switzerland. He was Chief Financial Officer Europe for Baxter International from 2002 to 2005, and Chief Financial Officer at ABB Group from 2005 to 2013. He also served as Interim CEO of ABB during 2008. He was independent vice-chairman at UBS Group from 2009 to 2019, and vice-chairman/chairman of Syngenta AG from 2013 to 2017.
Michel holds a degree in applied economics from the Université Catholique de Louvain and an MBA from the Katholieke Universiteit Leuven.
AstraZeneca PLC, non-executive chair, chair of the nomination and governance committee and member of the remuneration committee